ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 440,35
-0,18%
DAX
18 742,22
-0,08%
Brent Oil
82,975
0,72%
Bitcoin
62 733,24
2,10%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) Actualités

ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZIVO
DateHeureSourceTitreSymboleSociété
26/04/202419h36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202414h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202414h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
09/04/202417h49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
14/03/202414h16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/02/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
15/02/202414h54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/02/202422h54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
29/01/202414h00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
22/01/202423h15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
04/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
13/11/202322h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
03/11/202315h18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202313h30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202314h30Business WireZIVO Bioscience Announces Reverse Stock SplitNASDAQ:ZIVOZivo Bioscience Inc
04/10/202323h08Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ZIVOZivo Bioscience Inc
03/10/202314h30GlobeNewswire Inc.ZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ZIVOZivo Bioscience Inc
19/09/202322h15Business WireTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
16/08/202321h00Business WireZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsNASDAQ:ZIVOZivo Bioscience Inc
04/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZIVOZivo Bioscience Inc
03/08/202322h34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZIVOZivo Bioscience Inc
26/07/202322h15Business WireZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodNASDAQ:ZIVOZivo Bioscience Inc
17/07/202322h07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ZIVOZivo Bioscience Inc
05/07/202313h21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ZIVOZivo Bioscience Inc
30/06/202319h55Business WireZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-MarketNASDAQ:ZIVOZivo Bioscience Inc
28/06/202322h11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ZIVOZivo Bioscience Inc
28/06/202322h10Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:ZIVOZivo Bioscience Inc
16/06/202312h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZIVOZivo Bioscience Inc
30/05/202314h45Business WireZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientNASDAQ:ZIVOZivo Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:ZIVO

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
CAP
Capgemini
EU
BNP
BNP Paribas
EU
PX1
CAC 40
EU
BN
Danone
NYSE
DIS
Walt Disney
EU
RI
Pernod Ricard
EU
VK
Vallourec
EU
VIV
Vivendi
EU
DG
Vinci
SPI
SP500
S&P 500
EU
ACA
Credit Agricole
NYSE
MRK
Merck
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés